Molnupiravir; molecular and functional descriptors of mitochondrial safety
Authors:
- 28 March 2022
- journal article
- research article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 442, 116003
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Sensitivity of Mitochondrial Transcription and Resistance of RNA Polymerase II Dependent Nuclear Transcription to Antiviral RibonucleosidesPLOS Pathogens, 2012
- Mitochondrial DNA as a non-invasive biomarker: Accurate quantification using real time quantitative PCR without co-amplification of pseudogenes and dilution biasBiochemical and Biophysical Research Communications, 2011
- A high-throughput respirometric assay for mitochondrial biogenesis and toxicityAnalytical Biochemistry, 2010
- Structure-Activity Relationships and Human Relevance for Perfluoroalkyl Acid–Induced Transcriptional Activation of Peroxisome Proliferation in Liver Cell CulturesToxicological Sciences, 2009
- Roles of CHOP/GADD153 in endoplasmic reticulum stressCell Death & Differentiation, 2003
- Mitochondrial toxicity of nrti antiviral drugs: an integrated cellular perspectiveNature Reviews Drug Discovery, 2003
- Assessment of Mitochondrial Toxicity in Human Cells Treated with Tenofovir: Comparison with Other Nucleoside Reverse Transcriptase InhibitorsAntimicrobial Agents and Chemotherapy, 2002
- Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicityClinical Therapeutics, 2000
- Adverse effects of reverse transcriptase inhibitorsAIDS, 1998
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJNCI: Journal of the National Cancer Institute, 1990